Related Experiment Video
Updated: May 10, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Effects of caveolin-1 and P-ERK1/2 on Ang II-induced glomerular mesangial cell proliferation
1Department of Pediatrics, Second Affiliated Hospital of Guangzhou Medical University, No. 195 Dongfeng Xi Road, Guangzhou, China.
Abstract:
This study explored the effects of caveolin-1, p-ERK1/2 and transient receptor potential channel 6 (TRPC6) on angiotensin II (Ang II)-induced glomerular mesangial cell (GMC) proliferation, and investigated the role of Ang II on GMC proliferation. GMC cultures were divided into Control, Ang II (Ang II 10(-7 )mol/L), PD98059 (Ang II 10(-7 )mol/L + PD98059 5 × 10(-5 )mol/L) and MβCD groups (Ang II 10(-7 )mol/L + MβCD 10(-2 )mol/L). GMCs proliferation was measured by the methyl thiazolil tetracolium and trypan blue assays. The distribution of caveolin-1, p-ERK1/2 and TRPC6 was monitored by immunocytochemistry. Real time polymerase chain reaction (PCR) was used to assess mRNA expression of caveolin-1 and TRPC6. Western blot analysis was used to assess protein expression of caveolin-1, p-ERK1/2 and TRPC6. The results showed that Ang II promoted GMC proliferation. PD98059 and MβCD blocked Ang II-induced GMC proliferation, by 31.06% and 48.96%, respectively. In comparison with the control group, the expression of p-ERK1/2 and TRPC6 was significantly higher and caveolin-1 expression was significantly lower in the Ang II group. PD98059 markedly decreased p-ERK1/2 and TRPC6 expression and increased caveolin-1 expression. MβCD decreased the expression of p-ERK1/2 and TRPC6, but had no significant effect on caveolin-1 protein expression. These findings suggested that the intact caveolae structure was associated with Ang II-induced GMC proliferation, ERK1/2 activation and TRPC6 expression. And p-ERK1/2 acted as an upstream signal molecule for TRPC6. Moreover, p-ERK1/2 and caveolin-1 appeared to be inhibited reciprocally, thus regulated GMC proliferation by regulating TRPC6 expression.
Insights
Angiotensin II (Ang II) promotes glomerular mesangial cell proliferation, involving caveolin-1, p-ERK1/2, and TRPC6. Intact caveolae and ERK1/2 activation are crucial for Ang II-induced cell growth.
Area of Science:
- Cell Biology
- Physiology
- Molecular Biology
Background:
- Glomerular mesangial cells (GMCs) play a key role in kidney function and disease.
- Angiotensin II (Ang II) is a potent regulator of cardiovascular and renal function, implicated in GMC proliferation.
- Caveolin-1, p-ERK1/2, and TRPC6 are signaling molecules involved in cellular processes.
Purpose of the Study:
- To investigate the effects of Ang II on GMC proliferation.
- To explore the roles of caveolin-1, p-ERK1/2, and TRPC6 in Ang II-induced GMC proliferation.
- To elucidate the signaling pathways linking these molecules in GMCs.
Main Methods:
- GMC cultures were treated with Ang II, PD98059 (ERK inhibitor), or MβCD (cholesterol depletor).
- Cell proliferation was assessed using MTT and trypan blue assays.
- Expression and distribution of caveolin-1, p-ERK1/2, and TRPC6 were analyzed by immunocytochemistry, real-time PCR, and Western blot.
Main Results:
- Ang II significantly promoted GMC proliferation.
- PD98059 and MβCD inhibited Ang II-induced proliferation by 31.06% and 48.96%, respectively.
- Ang II increased p-ERK1/2 and TRPC6 expression while decreasing caveolin-1 expression. PD98059 and MβCD reversed these changes, with MβCD not affecting caveolin-1 protein levels.
Conclusions:
- Intact caveolae structure is associated with Ang II-induced GMC proliferation, ERK1/2 activation, and TRPC6 expression.
- p-ERK1/2 acts as an upstream signaling molecule for TRPC6.
- p-ERK1/2 and caveolin-1 exhibit reciprocal inhibition, collectively regulating GMC proliferation via TRPC6.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Regulation of Angiogenesis and Blood Supply
Endocrine Signaling
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

